• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

左心室肥厚：一个被忽视的心血管危险因素。

Left ventricular hypertrophy: an overlooked cardiovascular risk factor.

机构信息

Department of Internal Medicine, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

出版信息

Cleve Clin J Med. 2010 Jun;77(6):381-7. doi: 10.3949/ccjm.77a.09158.

DOI:10.3949/ccjm.77a.09158
PMID:20516249
Abstract

Left ventricular hypertrophy (LVH) is common in hypertensive patients, and it increases the risk of myocardial infarction, stroke, and death. Recent evidence indicates it is a modifiable risk factor that is not entirely dependent on blood pressure control. The authors review its pathogenesis, diagnosis, and treatment.

摘要

左心室肥厚（LVH）在高血压患者中很常见，它会增加心肌梗死、中风和死亡的风险。最近的证据表明，它是一个可改变的危险因素，不完全依赖于血压控制。作者回顾了其发病机制、诊断和治疗。

相似文献

1
Left ventricular hypertrophy: an overlooked cardiovascular risk factor.左心室肥厚：一个被忽视的心血管危险因素。
Cleve Clin J Med. 2010 Jun;77(6):381-7. doi: 10.3949/ccjm.77a.09158.
2
Left ventricular hypertrophy: a potent cardiovascular risk factor and its relationship to office and ambulatory blood pressure.左心室肥厚：一种强大的心血管危险因素及其与诊室血压和动态血压的关系。
Blood Press Monit. 1999;4 Suppl 1:S19-22.
3
Left ventricular hypertrophy: how to influence an important risk factor in hypertension.左心室肥厚：如何影响高血压中的一个重要危险因素。
J Hypertens Suppl. 1998 Jan;16(1):S53-8.
4
[The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study].氯沙坦与阿替洛尔对高血压合并心电图证实左心室肥厚患者心血管发病率及死亡率的影响： LIFE研究
Ugeskr Laeger. 2003 Jan 27;165(5):456-9.
5
Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients.高血压患者左心室肥厚的消退及心血管风险变化
Ital Heart J. 2004 Jul;5(7):505-10.
6
[Left ventricular hypertrophy--an important, often unrecognized risk factor].左心室肥厚——一个重要的、常未被识别的危险因素
Lakartidningen. 1998 Aug 5;95(32-33):3405-8.
7
Left ventricular hypertrophy: a pressure-independent cardiovascular risk factor.左心室肥厚：一种与压力无关的心血管危险因素。
J Cardiovasc Pharmacol. 1993;22 Suppl 1:S7-13.
8
Left ventricular hypertrophy and heart failure in women.女性的左心室肥厚与心力衰竭
J Hypertens Suppl. 2002 May;20(2):S34-8.
9
Left ventricular hypertrophy and clinical outcomes in hypertensive patients.高血压患者的左心室肥厚与临床结局
Am J Hypertens. 2008 May;21(5):500-8. doi: 10.1038/ajh.2008.16. Epub 2008 Mar 13.
10
Relation of electrocardiographic left ventricular hypertrophy to blood pressure, body mass index, serum lipids and blood sugar levels in adult Nigerians.成年尼日利亚人中心电图左心室肥厚与血压、体重指数、血脂及血糖水平的关系
Afr J Med Med Sci. 2003 Dec;32(4):395-9.

引用本文的文献

1
The impact of decreased SIRT1 levels on pediatric primary hypertension and left ventricular hypertrophy: a case-control study.SIRT1水平降低对小儿原发性高血压和左心室肥厚的影响：一项病例对照研究。
BMC Pediatr. 2025 Apr 30;25(1):340. doi: 10.1186/s12887-025-05671-z.
2
Association between obesity and new-onset heart failure among patients with hypertension in Thailand.泰国高血压患者中肥胖与新发心力衰竭之间的关联。
J Health Popul Nutr. 2024 Feb 29;43(1):33. doi: 10.1186/s41043-024-00530-6.
3
Association between AT1 receptor gene polymorphism and left ventricular hypertrophy and arterial stiffness in essential hypertension patients: a prospective cohort study.
血管紧张素 II 型受体基因多态性与原发性高血压患者左心室肥厚及动脉僵硬度的相关性：一项前瞻性队列研究。
BMC Cardiovasc Disord. 2022 Dec 28;22(1):571. doi: 10.1186/s12872-022-03024-7.
4
Assessment of subclinical cardiovascular alterations in nonfunctioning adrenal incidentalomas.评估无功能性肾上腺意外瘤的亚临床心血管改变。
Turk J Med Sci. 2022 Jun;52(3):677-682. doi: 10.55730/1300-0144.5360. Epub 2022 Jun 16.
5
Knockout of AMPKα2 Blocked the Protection of Sestrin2 Overexpression Against Cardiac Hypertrophy Induced by Pressure Overload.敲除AMPKα2可阻断Sestrin2过表达对压力超负荷诱导的心肌肥大的保护作用。
Front Pharmacol. 2021 Nov 17;12:716884. doi: 10.3389/fphar.2021.716884. eCollection 2021.
6
Pharmacotherapy for hypertension-induced left ventricular hypertrophy.高血压性左心室肥厚的药物治疗。
Cochrane Database Syst Rev. 2021 Oct 10;10(10):CD012039. doi: 10.1002/14651858.CD012039.pub3.
7
Performance of a novel ECG criterion for improving detection of left ventricular hypertrophy: a cross-sectional study in a general Chinese population.一种新型心电图标准改善左心室肥厚检测性能的研究：一项中国一般人群的横断面研究。
BMJ Open. 2021 Sep 2;11(9):e051172. doi: 10.1136/bmjopen-2021-051172.
8
The association between ECG criteria and Echo criteria for left ventricular hypertrophy in a general Chinese population.在一般的中国人群中，心电图标准与超声心动图标准左心室肥厚的相关性。
Ann Noninvasive Electrocardiol. 2021 Sep;26(5):e12880. doi: 10.1111/anec.12880. Epub 2021 Jul 26.
9
Accuracy of the novel Peguero Lo-Presti criterion for electrocardiographic detection of left ventricular hypertrophy in a black African population.新型 Peguero Lo-Presti 标准在黑非洲人群中心电图检测左心室肥厚的准确性。
J Clin Hypertens (Greenwich). 2021 Jun;23(6):1186-1193. doi: 10.1111/jch.14243. Epub 2021 Mar 29.
10
Going beyond Cardiomegaly: Evaluation of Cardiac Chamber Enlargement at Non-Electrocardiographically Gated Multidetector CT: Current Techniques, Limitations, and Clinical Implications.超越心脏扩大：非心电门控多层螺旋CT对心腔扩大的评估：当前技术、局限性及临床意义
Radiol Cardiothorac Imaging. 2019 Apr 25;1(1):e180024. doi: 10.1148/ryct.2019180024. eCollection 2019 Apr.